EVO exerts cytotoxic effects on breast cancer cells, and the effects include cell cycle arrest, a decrease in cyclin D1 expression, and induction of cell apoptosis [42,47]; Furthermore effects of EVO on human hepatocellular carcinoma [48] and gastric tumors have been proven [49]. Here, CCND1 is linked to breast cancer.